Analyst Reco. Elevance Health, Inc.

Equities

ELV

US0367521038

Market Closed - Nyse Other stock markets 04:00:02 2024-07-05 pm EDT			5-day change	1st Jan Change
530.3 ^USD	-0.02%		-2.13%	+12.46%

Jul. 01	Elevance Health, Inc.(NYSE:ELV) dropped from Russell 1000 Dynamic Index	CI
Jun. 14	Investors need more time to assess Fed comments

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

ANALYST RECOMMENDATIONS : Adobe, Bank of America, Boeing, Nvidia, Wise...	Jun. 14
BofA Securities Raises Price Target on Elevance Health to $646 From $621, Maintains Buy Rating	Jun. 04	MT
BofA Securities Adjusts Price Target on Elevance Health to $646 From $621, Maintains Buy Rating	Jun. 04	MT
JPMorgan Adjusts Price Target on Elevance Health to $631 From $628	May. 30	MT
Baird Initiates Elevance Health With Outperform Rating, $649 Price Target	May. 30	MT
Argus Raises Elevance Health's Price Target to $600 From $540	Apr. 30	MT
Elevance Health Insider Sold Shares Worth $10,832,155, According to a Recent SEC Filing	Apr. 25	MT
Mizuho Adjusts Price Target on Elevance Health to $585 From $575	Apr. 24	MT
TD Cowen Adjusts Elevance Health's Price Target to $624 From $555	Apr. 23	MT
UBS Adjusts Price Target on Elevance Health to $605 From $585, Maintains Buy Rating	Apr. 19	MT
Bernstein Adjusts Price Target on Elevance Health to $665 From $629	Apr. 19	MT
Leerink Partners Adjusts Elevance Health Price Target to $630 From $565	Apr. 19	MT
Jefferies & Co Adjusts Elevance Health Price Target to $604 From $602	Apr. 19	MT
Goldman Sachs Raises Elevance Health's Price Target to $600 From $578	Apr. 19	MT
RBC Lifts Price Target on Elevance Health to $575 From $574, Cites 'Stronger Guidance,' Keeps Outperform Rating	Apr. 19	MT
Truist Lifts Price Target on Elevance Health to $600 From $580, Notes 'Solid' Q1, 2024 Guidance Boost, Keeps Buy Rating	Apr. 19	MT
Wells Fargo Adjusts Elevance Health's Price Target to $600 From $557, Maintains Overweight Rating	Apr. 19	MT
Barclays Adjusts Elevance Health's Price Target to $621 From $584, Maintains Overweight Rating	Apr. 19	MT
Cantor Fitzgerald Raises Elevance Health Price Target to $600 from $580	Apr. 18	MT
Stephens Adjusts Elevance Health's Price Target to $615 From $580	Apr. 18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Elevance Health, Inc.

Equities

ELV

US0367521038

Analyst Reco.

Filters